Proshares Trust (ZBIO) Payables (2023 - 2025)
Historic Payables for Zenas BioPharma (ZBIO) over the last 3 years, with Q3 2025 value amounting to $6.4 million.
- Zenas BioPharma's Payables fell 5727.36% to $6.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.4 million, marking a year-over-year decrease of 5727.36%. This contributed to the annual value of $17.1 million for FY2024, which is 21756.86% up from last year.
- Per Zenas BioPharma's latest filing, its Payables stood at $6.4 million for Q3 2025, which was down 5727.36% from $7.9 million recorded in Q2 2025.
- In the past 5 years, Zenas BioPharma's Payables ranged from a high of $20.0 million in Q1 2025 and a low of $5.4 million during Q4 2023
- Its 3-year average for Payables is $12.0 million, with a median of $11.5 million in 2024.
- As far as peak fluctuations go, Zenas BioPharma's Payables skyrocketed by 21756.86% in 2024, and later tumbled by 5727.36% in 2025.
- Zenas BioPharma's Payables (Quarter) stood at $5.4 million in 2023, then soared by 217.57% to $17.1 million in 2024, then crashed by 62.39% to $6.4 million in 2025.
- Its Payables stands at $6.4 million for Q3 2025, versus $7.9 million for Q2 2025 and $20.0 million for Q1 2025.